We are live on ! Find out more
BMY icon

Bristol-Myers Squibb
BMY

1,179 hedge funds and large institutions have $49.8B invested in Bristol-Myers Squibb in 2013 Q2 according to their latest regulatory filings, with 1,179 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

68.53% more ownership

Funds ownership: 0% → 68.53% (+69%)

1% more call options, than puts

Call options by funds: $519M | Put options by funds: $516M

Holders
1,179
Holders Change
+1,179
Holders Change %
–
% of All Funds
38.47%
Holding in Top 10
49
Holding in Top 10 Change
+49
Holding in Top 10 Change %
% of All Funds
1.6%
New
1,179
Increased
–
Reduced
–
Closed
–
Calls
$519M
Puts
$516M
Net Calls
+$2.99M
Net Calls Change
+$2.99M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CCM
501
Catawba Capital Management
Virginia
$2.61M +$2.54M +58,495 New
KB
502
Kimelman & Baird
New York
$2.61M +$2.53M +58,384 New
AT
503
Arden Trust
Delaware
$2.58M +$2.5M +57,617 New
III
504
Independent Investors Inc
New York
$2.57M +$2.5M +57,600 New
ATC
505
Argent Trust Company
Louisiana
$2.56M +$2.49M +57,317 New
SAM
506
Sawgrass Asset Management
Florida
$2.52M +$2.45M +56,330 New
CB
507
Chemical Bank
Michigan
$2.51M +$2.44M +56,264 New
WFMPM
508
Woodley Farra Manion Portfolio Management
Indiana
$2.5M +$2.43M +55,868 New
HVIA
509
Hudson Valley Investment Advisors
New York
$2.48M +$2.41M +55,495 New
HHC
510
Hutchin Hill Capital
New York
$2.48M +$2.41M +55,500 New
KBG
511
Kahn Brothers Group
New York
$2.48M +$2.41M +55,433 New
First Manhattan
512
First Manhattan
New York
$2.46M +$2.45M +56,352 New
SAG
513
Sterne Agee Group
Alabama
$2.46M +$2.39M +55,138 New
MM
514
Midas Management
New York
$2.46M +$2.39M +55,000 New
CIA
515
Choate Investment Advisors
Massachusetts
$2.45M +$2.38M +54,836 New
SC
516
SouthState Corp
Florida
$2.45M +$2.38M +54,785 New
JG
517
Jefferies Group
New York
$2.44M +$2.37M +54,653 New
I
518
IberiaBank
Louisiana
$2.43M +$2.36M +54,392 New
FMW
519
Farr Miller & Washington
District of Columbia
$2.42M +$2.36M +54,252 New
B
520
Barings
North Carolina
$2.42M +$2.35M +54,179 New
WS
521
Wedbush Securities
California
$2.41M +$2.34M +53,875 New
CT
522
Cambridge Trust
Massachusetts
$2.4M +$2.34M +53,803 New
BFM
523
Boston Financial Management
Massachusetts
$2.4M +$2.33M +53,658 New
FSC
524
Fiduciary Services Corp
Georgia
$2.38M +$2.31M +53,322 New
SCM
525
Stux Capital Management
New York
$2.36M +$2.29M +52,800 New
19 20
21
22 23

BMY Hedge Fund Activity: Q2 2013 in Review

1,179 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q2 2013, worth a combined $49.8B.

Buyers outnumbered sellers: 1,179 funds opened new BMY positions and 0 closed out — a net gain of 1,179 holders — while 0 added to existing stakes and 0 trimmed.

  • 1,179 institutional investors held Bristol-Myers Squibb (BMY) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $49.8B of Bristol-Myers Squibb stock for Q2 2013.
  • 1,179 funds opened new Bristol-Myers Squibb positions in Q2 2013 and 0 closed out, a net change of +1,179 holders.

Based on aggregated 13F filings for Q2 2013.